Deals roundup: Celera to acquire BHL for $195M, no word on split from Applera Sep. 6, 2007 By Omar Ford
NewCo News: Mithridion Uses Neuroprotective Pathway To Target Alzheimer's Sep. 6, 2007 By Trista Morrison
BDSI, Meda Partner On $90M+ Licensing Deal For Opioid Disc Sep. 6, 2007 By Donna Young BioDelivery Sciences International Inc. is set to receive $30 million in an up-front payment from Swedish specialty pharma Meda AB under a licensing agreement for BEMA Fentanyl, a dissolvable opioid disc product. (BioWorld Today)Read More
RSS